In This Section

Global Health Informatics Speaker Series Session - October 27, 2022

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

2 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Date:
Oct 27, 2022
-
Event Start Time
12:00 pm to
Event End Time
1:00 pm
Where:

All CHOP Research Locations

Join us on October 27 for Session Four of the Global Health Informatics Fall Speaker Series!

In this session, Dr. Terry Cullen, Dr. Paul Biondich, and Dr.Boonchai Kijsanayotin will review the technical innovations happening globally to connect health information data. We will discuss population health informatics, FHIR/WHO efforts, interoperability/data standards and funding opportunities that researchers at CHOP/Penn can apply for.

Register here

Stay tuned for information about a Virtual Community-Building Coffee Hour in November, where you can join series speakers to discuss convergent areas of global health informatics work, Potential collaborations and education needs.

For more information, email ghi@chop.edu.

Connect with us at www.research.chop.edu/global-health-informatics.

 

Clinical RSS Activity Statements

ACCME Accreditation Statement: Children’s Hospital of Philadelphia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement: Children’s Hospital of Philadelphia designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement: Steven Wanyee, MSc (Speaker), Chris Lehmann, MD (Speaker), Andrew Steenhoff, MD (Speaker), Anthony Luberti, MD (CME Course Director), Sansanee Craig, MD (Planner), Grey Faulkenberry, MD (Planner), Hannah Bocchinfuso (Planner), Mark Diltz, EdD (Planner) and Amy Gettlin (CME Accreditation Manager) and others as appropriate have no relevant financial relationship with an ineligible company to disclose.